top of page
Broadreach Global logo white

SHARE

  • LinkedIn
  • Twitter
TNS LOGO Transparent

THE NEURO SUMMIT

NeuroTech, Digital Health, DeepTech,
Data & A.I.

Broadreach Global logo white

 TM

Oct. 29 - 31

2024

Champalimaud Foundation,

Lisbon, Portugal

Innovation & Partnering at the confluence of Neuroscience and Mental Health with NeuroTech, Digital Health, DeepTech, Data & Artificial Intelligence.

Welcome
About
ABOUT
Insight - Innovation - Access - Engagement - Partnering

The one summit which convenes a high level, by-invitation, boutique
gathering of key thought leaders, innovators and decision-makers from all key stakeholder groups in digital health, neurotech and A.I. for neurosciences and mental health.  Addressing not only opportunities but also the core challenges facing companies and stakeholders. Sharing models, lessons learned, mistakes, solutions, ways forward and best practices. Fostering a unique level of sustained high-quality discussion, access, engagement and partnering in a truly curated  summit unlike any other event. 

 
Champalimaud Foundation Auditorium entrance
VISION

Convening the full value chain to disrupt silos and curate highly interactive, multi-disciplinary, cross-industry, and multi-stakeholder discussions of opportunities, challenges, hurdles and ways forward.

 

Drive transformational connections, discussion and partnering for startups and growth companies. 

 

Deliver insight, access, engagement and partnering to foster innovation and accelerate value creation.

 

Contribute to meaningful improvement in healthcare outcomes and positive impact for patients and society.  

WHY NOW?

From A.I. enabled drug discovery and development, big data, digital biomarkers, Real World Data and trial design, to advanced imaging, companion digital health, cognitive behavioral therapy and connected health, to neuromodulation and V.R., the pace of innovation is unprecedented.

 

Paradigms are changing, and the potential for positive impact on patient outcomes and quality of life, improved delivery of care, healthcare expenditure, and societal benefit are enormous.

The Neuro Summit is an initiative of Broadreach Global, and is co-organized with the Champalimaud Foundation, with support of Global Innovation Partners.

 

The first editions in 2022 and 2023 delivered  unique, meaningful and high-impact convenings, a who's who of key leaders, innovators and decision-makers. Be a part of it in 2024.

IMG_3917_edited.jpg
PRESENTING COMPANIES

Join a curated selection of the best, world-class , innovative  neuro and mental health companies in NeuroTech, Digital,  DeepTech, Data & A.I. with potential to transform healthcare, patient outcomes or markets.  Selection is by excellence and potential, not by price tag!

There is no cost to present beyond the regular startup or private company registration fees.

Benefit from:

- Pre-summit guidance and feedback on your deck.

- An on-site dry-run presentation with feedback and coaching from expert mentors.

- A 5 minute pitch plus 3 minutes of Q&A with an expert panel of relevant investors and industry: In the plenary session.

- Exclusive post presentation meeting space:  

      - Meeting Space: A reserved meeting space, prominently         placed in the main networking area.

      - For 45 minutes in the networking break immediately                          following the presentation session.

- 2 Days of sustained engagement with the best network of innovators, investors, industry leaders & decision-makers in NeuroTech, Neuro Digital Health, MedTech, DeepTech & A.I.

- Option to add an exclusive company exhibition stand.

shutterstock_1707864103.jpg

Broadreach Summits - What Participants Say

"...Nothing short of incredible. So many brilliant innovators, policymakers, researchers and investors all with the same mission to advance brain health. I was in awe of this groundbreaking growing community and humbled to be invited to take part in it."

Noga Sapir, Founder & CEO -

 Reflect Innovation (Israel)

Neuromn image iStock-937894966_edited.jpg

ADVISORY BOARD - announcing the initial members of the 2024 Advisory Board 

We are honored to introduce our advisory board: meet them in person at the summit.

Joe Paton

Joe Paton

Director of Neuroscience & Principal Investigator, Champalimaud Foundation

Ana Maiques

Ana Maiques

CEO & Co-Founder, Neuroelectrics

John Krakauer

John Krakauer

Professor of the Unknown – Champalimaud Foundation, Professor of Neurology, Neuroscience, and Physical Medicine and Rehabilitation, Director, Brain, Learning, Animation, and Movement - The Johns Hopkins University School of Medicine, Chief Medical Director - Mindmaze

Sourav Kole

Sourav Kole

Managing Director Life Sciences - Dolby Family Ventures

Beth Wolff

Beth Wolff

Director Digital Health Solutions, Global Business Development & Licensing - Lundbeck

Pawel Swieboda

Pawel Swieboda

Founder - NeuroCentury; Practice Lead Neurotechnology, ICFG; Senior Advisor on Brain Health, FIPRA

Georgia Mitsi

Georgia Mitsi

Partner, Business & Competitive Strategy - Y Innovations

Gilad Peleg

Gilad Peleg

Founding Partner - Neuro1 Capital, Formerly Founding Partner, Corundum Open Innovation & Joy Ventures

Martien Kas

Martien Kas

President - European College of NeuroPsychopharmacology (ECNP)

Joachim Scholpp

Joachim Scholpp

Global Head Translational Medicine CNS & Emerging Areas, Boehringer Ingelheim, Germany

Paulo Machado

Paulo Machado

CEO/Founder - Health Innovation Partners, Angel - What if Ventures, Strategic Advisor - Meadows Mental Health Policy Institute

Christian J. Suojanen

Christian J. Suojanen

Founder & CEO - Broadreach Global, Member of the Board - European Brain Foundation (EBF)

Advisors
Human brain on a dark blue background. Digital illustration.jpg

SPEAKERS 2023 - the 2024 lineup of speakers will be announced starting in May.

Proudly convening leading speakers and stakeholders from across the sector
Speakers
John Krakauer

John Krakauer

Professor of Neurology, Neuroscience, and Physical Medicine & Rehabilitation - Johns Hopkins School of Medicine (Maryland)

Ana Maiques

Ana Maiques

CEO & Co-Founder - Neuroelectrics (Barcelona)

Zenna Tavares

Zenna Tavares

Founder & Director - Basis Research Institute, Research Scientist - Data Science Institute & Innovation Fellow - Zuckerman Mind Brain Behavior Institute - Columbia University, New York

Daniela Pimenta da Silva

Daniela Pimenta da Silva

Neurologist and PhD student - CNS-Campus Neurologico and Faculty of Medicine of the University of Lisbon

Daniel Wetmore

Daniel Wetmore

Senior Research Scientist - Meta Reality Labs, Director, Clinical & Research Partnerships - CTRL-labs, NY

Joe Paton

Joe Paton

Director of Neuroscience & Principal Investigator, Champalimaud Foundation

Joachim Scholpp

Joachim Scholpp

Global Head Translational Medicine CNS & Emerging Areas, Boehringer Ingelheim, Germany

Nick Taptiklis

Nick Taptiklis

Head of Technology Strategy - Cambridge Cognition (UK)

Georgia Mitsi

Georgia Mitsi

Enterpreneur in Residence - Emerald BioVentures (Boston)

Pawel Swieboda

Pawel Swieboda

Founder - NeuroCentury; Practice Lead Neurotechnology, ICFG; Senior Advisor on Brain Health, FIPRA

Ariane Tom, PhD

Ariane Tom, PhD

Founding Partner - Kaleida Capital (San Diego)

David Braga Malta

David Braga Malta

Life Sciences Investor & Entrepreneur - PE Thematic Health, Pictet Bank (Switzerland)

Paulo Machado

Paulo Machado

CEO/Founder - Health Innovation Partners, Angel - What if Ventures, Strategic Advisor - Meadows Mental Health Policy Institute

Amir Bozorgzadeh

Amir Bozorgzadeh

Co-Founder & CEO - Virtuleap

Bruno Montanari

Bruno Montanari

Partner - Seroba Life Sciences, Paris

Beth Wolf

Beth Wolf

Director Digital Health Solutions, Global Corporate Strategy & BD - Lundbeck, Copenhagen

Mark Treherne

Mark Treherne

Chairperson - Monument Therapeutics. Commercial Scientist, Entrepreneur & Investor. Chairperson of Talisman Therapeutics, Ubiqent, NuVision Biotherapies (UK)

Julia Prakapovich

Julia Prakapovich

Partner - Interface Fund (London)

Dan Mannix

Dan Mannix

CEO - Advisor - Brain Health Investor, former CEO - RWC Partners (UK)

Tiago Marques

Tiago Marques

Senior Research Scientist - Champalimaud Foundation, Chief Technology Office - HEKA vision, Lisbon

Razi Syed

Razi Syed

Head of Product - Sahha

Xavier Louis

Xavier Louis

Co-founder & CEO - Five Lives

Carla Zaldua Aguirre,

Carla Zaldua Aguirre,

Co-Founder & CEO - acceXible

Olivier de Simone

Olivier de Simone

Co-Founder & CEO - Sensae

Dr. Laura Murray

Dr. Laura Murray

Clinical Psychologist, CEO/Founder - CETA Global; Senior Scientist - Johns Hopkins Bloomberg School of Public Health, Entrepreneur, Researcher and Clinician (Maryland)

Joshua Haynes

Joshua Haynes

Founder & Managing Partner - Masawa Fund (Berlin)

Shwen Gwee

Shwen Gwee

Digital Health & Corporate Innovation Executive, ex BMS Global Head of Digital Strategy, ex-Novartis BIOME & Open Innovation co-founder (Boston)

Hossein Jalali

Hossein Jalali

Cofounder & CTO - Virtuleap

Naomi Glover

Naomi Glover

Co-Founder/Director - Applied Neuroscience Association (London)

Hannes Klöpper

Hannes Klöpper

CEO - HelloBetter Co-Chair - European Policy Task Group of the Digital Therapeutics Alliance

Marco Mohwinckel

Marco Mohwinckel

Mental Health Executive & Investor, Chairman – Altibbi, Director - Magnolia Health Advisors (London)

Xavier Palomer Ripoll

Xavier Palomer Ripoll

Founder - Amelia Virtual Care

Amanda Borgerhoff

Amanda Borgerhoff

Vice President Client Services - Warman O'Brien

JP Borges

JP Borges

Managing Partner - JP Borges Abogados, Co-Founder - Exputnik Accelerator (Spain)

Mick Walsh

Mick Walsh

VP Commercial & Business Development - Head Diagnostics (Ireland)

Hana Besbes

Hana Besbes

Investor - Heal Capital (Berlin)

Jason Dictenberg

Jason Dictenberg

Investor, Executive, CEO - AccelBio, Chairman - Evergreen Biosciences, Advisory Board Member - Alzheimer's Drug Discovery Foundation, Editor - CellR4 Journal on Regenerative Medicine (New York)

Richard Stokvis

Richard Stokvis

Managing Director - BOA Healthcare Holdings Limited

Lorena Muñoz Vivas

Lorena Muñoz Vivas

CEO - Effectia Consulting (Spain)

Christian J. Suojanen

Christian J. Suojanen

CEO - Broadreach Global, Member of the Executive Board - European Brain Foundation (USA)

2OI8RM

Lisbon, Portugal. Cityscape iImage of Lisbon, Portugal during dramatic sunrise..jpg
Participants

WHO'S COMING?

Two days of sustained, interactive discussion, networking and partnering with:

1927C921-5F3F-4BA4-A0FF-1C3FBE294172_edi

Industry Leaders

Senior industry executives from pharma, digital health, technology & health providers & systems. Heads of therapeutic area, R&D, real world data, clinical development, digital health, scouting, business development & licensing.

IMG_4950_edited_edited.png

Key Opinion Leaders

Key Opinion Leaders from all stakeholder groups at the confluence of neurosciences & mental health with digital, technology, data and A.I.

IMG_3879_edited.jpg

Founders & CEOs

From startup and growth companies at the confluence of  neuroscience and mental health with digital, medtech, imaging, technology, data and A.I.

Government and NGO image

Government & NGOs

Public agencies, societies, associations & NGOs in brain health, neurology, neurosciences, psychiatry & mental health, patient organizations, economic development, health, research & innovation.

Screenshot 2024-02-21 at 6.37_edited.jpg

Investors

In CNS, neuroscience and mental health, data, health tech, digital health, A.I. and deeptech.

VC and corporate venture, private equity, family offices, angels & HNW. 

Strategy image by Karmakar

Leading Advisors

A selected group of leading specialized advisors and consultants with deep subject matter expertise relevant to participants. 

Venue

VENUE

Champalimaud Foundation

Av. Brasília, 1400-038

Lisbon, Portugal

The Champalimaud Foundation carries out research in cutting-edge fields and strives to stimulate discoveries that benefit people, and to promote new standards of knowledge.

It is at the Champalimaud Centre for the Unknown, in Lisbon, that the Foundation develops its activity in the areas of neuroscience and cancer. This is done through both research programmes and the provision of clinical services of excellence. It also has an outreach programme to fight blindness.

To pursue its objectives in achieving significant scientific advances, the Champalimaud Foundation adopts a translational methodology, which establishes a direct link and interdependency between basic research and clinical activity. This is a fundamental part of the Foundation’s methodology.

Ultimately, the Champalimaud Foundation aims to promote the health and well-being of humankind by seeking to actively participate in the search for solutions that can alleviate the burden of disease on societies and individuals.

CO-ORGANIZED WITH

Champalimaud Foundation logo

STRATEGIC PARTNERS & SPONSORS
 

Sponsors

GOLD SPONSOR
 

WOB-logo-portrait

STRATEGIC PARTNERS

Effectia-Logo
JP Borges logo

ASSOCIATION PARTNERS

The_EBC_logo SMALL.png
ECNP_LOGO_TAGLINE_RGB.jpg
BID logo.png
PAREA logo
Round Applied Neuroscience Logo
Enquiries

GET IN TOUCH

Reach us here if you like to

  • Nominate a speaker

  • Apply to present your company or technology

  • Enquire about sponsorship & exhibition opportunities

Thanks, message received. We'll be in touch shortly.

Subscribe

Be the first to know

Subscribe and be among the first to receive all updates, announcements and invitations.

Please make sure to double check your email address.

Thanks for subscribing!

shutterstock brain scan v2

SHARE

  • LinkedIn
  • Twitter

A Broadreach Global Initiative

Contact us at: 

Follow us

Broadreach Global Logo White
Copyright © 2023. All rights reserved. Broadreach Global LLC.
  • LinkedIn
bottom of page